Delivery Order SPE2D018D0006-SPE2D326F0796
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order contract valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 21, 2025, was issued without set-aside designation under firm fixed-price terms. Performance will take place in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal...
- Eagle Pharmaceuticals, Inc. has been awarded a $4,874.13 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 250mg vials of the drug Ryanodex. As the prime contractor, Eagle Pharmaceuticals will deliver the specified pharmaceutical products to DLA Troop Support Medical's place of performance in Westwood, New Jersey by November 15, 2023. No major subcontractors or joint venture partners are involved. The delivery order was...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia. The contract has a ceiling value of $10,161.24 and is a firm fixed price delivery order that runs through August 2024. Eagle Pharmaceuticals is a specialized pharmaceutical company that provides critical medications to the U.S. federal...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
- The U.S. Department of Defense Medical Supply Chain has awarded a $10,585.32 firm fixed-price purchase order to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, a critical injectable medication. The contract, designated as a Total Small Business set-aside, was awarded on September 3, 2025, with an ultimate completion date of September 18, 2025. Performance will take place in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc. a $4,874.13 firm fixed price delivery order for 4561531114 RYANODEX 250 MG VIAL. Eagle Pharmaceuticals will deliver the pharmaceutical products to a location in Westwood, New Jersey by July 18, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring food, clothing, medicines, medical supplies and equipment for troops. This delivery order was issued against an...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $9,632.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ryanodex 250 mg vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ryanodex is a rapid-sequence intubation agent used in emergency...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $6,421.76 firm fixed-price delivery order for 250 mg vials of Ryanodex, a muscle relaxant used primarily in anesthesia and critical care settings. This non-competitive delivery order, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 250 mg vials of the drug Ryanodex, with a ceiling value of $5,716.40. The order was awarded on April 12, 2023 and has a...
- SPE2D018D0006Indefinite Delivery Contract
- SPE2D018D0006-SPE2D326F0796Delivery Order
Eagle Pharmaceuticals, Inc. was awarded a delivery order valued at $10,585.32 by the Defense Logistics Agency Troop Support Medical division of the Medical Supply Chain for the procurement of Ryanodex 250 mg vials, a specialized injectable medication used to treat and prevent malignant hyperthermia. The contract, which carries no set-aside designation and operates on a firm fixed-price basis, was awarded on October 22, 2025, with an ultimate completion date of October 27, 2025. Performance will take place at Eagle Pharmaceuticals' manufacturing facility located in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Integrated Service Network 12, a multiple-award vehicle valued at $30.89 million through January 31, 2029. As a specialized supplier of critical injectable pharmaceuticals to federal healthcare agencies, Eagle Pharmaceuticals serves as the prime contractor with no identified subcontractors and has established itself as a reliable vendor within the federal medical supply chain for both the Department of Defense and the Department of Veterans Affairs through consistent performance on similar pharmaceutical procurement awards since 2016.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 10/22/25 |